Cannara Biotech Inc. LOVFF
1.45 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
1.45 Day range 1.45
1.11 52-week range 1.66
- YTD
- +14.17%
- 1 year
- +20.83%
News
globenewswire.com Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion Cannara reports record Q3 2026 revenue, continued profitability, broader national distribution and accelerated capacity expansion to meet growing demand.
globenewswire.com Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec Cannara Releases Q2 FY26 Results: $27.2M revenue, 43% GM, $6.0M Adj. EBITDA, OCF $2.9M; 4.4% national share, #1 Québec; Valleyfield expansion progressing.
newsfilecorp.com Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis…
newsfilecorp.com Cannara Biotech Inc. (LOVE) Opens the Market Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Donald Olds, Lead Director and Chairman of the Audit and Governance Committee, Cannara Biotech Inc. ("Cannara" or the "Company") (TSX: LOVE),…
globenewswire.com Cannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category Launch MONTREAL, Québec, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of…
benzinga.com 'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report https://abcnews.go.com/Politics/trump-sign-executive-order-reclassifying-marijuana-officials/story?id=128472615
globenewswire.com Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade…
globenewswire.com Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance MONTREAL, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade…
globenewswire.com Cannara Announces Grant of Options and RSUs MONTREAL, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade…
globenewswire.com Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield Cannara secures $10M BMO credit facility upsize to fund Valleyfield expansion, building post-harvest capacity toward 100,000 kg annual cannabis production.
globenewswire.com Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale MONTREAL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of…
globenewswire.com Cannara Secures 5 Key Listings in Québec's New Vape Cartridge Category Including to be Released Live Rosin Vapes MONTREAL, July 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade…
globenewswire.com Cannara Biotech to Host Investor Webcast on June 25th, 2025 Cannara Biotech (TSXV: LOVE) to host investor webcast on June 25 to discuss growth, operations, and strategy. Register now to join the live Q&A session.
benzinga.com 'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report https://www.marijuanamoment.net/gop-led-congressional-panel-demands-investigation-on-bidens-marijuana-rescheduling-process-citing-deviations-and-mental-health-hazards/
seekingalpha.com Cannara Biotech Inc. (LOVFF) Q2 2025 Earnings Call Transcript Cannara Biotech Inc. (OTCQB:LOVFF) Q2 2025 Earnings Conference Call April 29, 2024 11:00 AM ET Company Participants Scott Carroll - VP Commercial Strategy & Marketing Nicholas Sosiak - Chief…
globenewswire.com Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors Cannara Biotech appoints Justin Cohen to its Board of Directors, enhancing brand strategy with his extensive marketing and digital transformation expertise
benzinga.com Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says' https://www.marijuanamoment.net/trump-white-house-invites-proposal-on-federal-marijuana-legalization-activist-says/
globenewswire.com Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike Cannara announces its 2024 AGM will be virtual. Due to a postal strike. Proxy materials are online, and exemptions apply under CSA Blanket Order 51-913
globenewswire.com Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024 MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of…
globenewswire.com Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023. Robust growth in Q4 over Q3 2024, with total…
globenewswire.com Cannara Biotech Reports Q3 2024 Financial Results Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity
prnewswire.com Cannara Biotech Reports Q2 2024 Financial Results Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0 million…
prnewswire.com Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion Record Q1 net revenues of $19.5 million, representing an 89% increase compared to the $10.3 million of net revenues generated in Q1 2023 Q1 operating income of $3.4 million, representing an 201%…
benzinga.com Cannabis Stock Gainers And Losers From July 25, 2023 GAINERS: EVIO (OTC:EVIO) shares closed up 4900.00% at $5e-05